SCHEMBL30633352

SCHEMBL30633352

Nc1n[nH]c2ccc(-c3ccnc(NC(=O)Nc4ccccc4)c3)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 6/20 0.56
▸ JAK1 P23458 2/20 0.56
▸ MAPK1 P28482 2/20 0.55
▸ CNR1 P21554 1/20 0.55
▸ KDR P35968 6/20 0.52
▸ FLT3 P36888 3/20 0.52
▸ AURKB Q96GD4 3/20 0.52
▸ AURKA O14965 3/20 0.52
▸ DYRK1A Q13627 3/20 0.52
▸ MARK2 Q7KZI7 3/20 0.52
▸ PLK4 O00444 2/20 0.52
▸ ROCK2 O75116 2/20 0.52
▸ CHEK2 O96017 2/20 0.52
▸ NTRK1 P04629 2/20 0.52
▸ LCK P06239 2/20 0.52
▸ CSF1R P07333 2/20 0.52
▸ LYN P07948 2/20 0.52
▸ KIT P10721 2/20 0.52
▸ FLT1 P17948 2/20 0.52
▸ FLT4 P35916 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26685861 1.00 JAK2 (0.56) JAK2JAK1MAPK1CNR1KDR
SCHEMBL26686370 0.91 JAK2 (0.61) JAK2JAK1MAPK1CNR1KDR
SCHEMBL31420124 0.91 JAK2 (0.61) JAK2JAK1MAPK1CNR1KDR
SCHEMBL30633362 0.90 JAK2 (0.53) JAK2JAK1MAPK1CNR1KDR
SCHEMBL26686348 0.89 DYRK1A (0.52) JAK2MAPK1KDRDYRK1ACLK2
SCHEMBL30633283 0.89 DYRK1A (0.52) JAK2MAPK1KDRDYRK1ACLK2
SCHEMBL30633357 0.89 FLT1 (0.47) JAK2JAK1MAPK1CNR1KDR
SCHEMBL26686209 0.89 FLT1 (0.47) JAK2JAK1MAPK1CNR1KDR
SCHEMBL30633403 0.89 JAK2 (0.57) JAK2MAPK1CNR1KDRFLT3
SCHEMBL30633323 0.89 CNR1 (0.61) JAK2JAK1MAPK1CNR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback